First Trust Advisors LP Castle Biosciences Inc Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$33.17 - $46.98 $263,237 - $372,833
-7,936 Closed
0 $0
Q4 2021

Feb 08, 2022
SELL
$39.06 - $67.58 $297,363 - $514,486
-7,613 Reduced 48.96%
7,936 $340,000
Q3 2021

Nov 15, 2021
BUY
$60.13 - $77.6 $419,707 - $541,648
6,980 Added 81.46%
15,549 $1.03 Million
Q2 2021

Aug 16, 2021
BUY
$50.07 - $76.78 $429,049 - $657,927
8,569 New
8,569 $628,000

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $748M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email